title: [The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis].
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Surushkina
authors.forename: I S
authors.initials: IS
authors.lastname: Nikishena
authors.forename: E A
authors.initials: EA
authors.lastname: Iakovenko
authors.forename: O V
authors.initials: OV
authors.lastname: Lapshina
authors.forename: T I
authors.initials: TI
authors.lastname: Anisimova
mesh_terms: D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000069445:Atomoxetine Hydrochloride; D001288:Attention / Q000187:drug effects / Q000502:physiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005500:Follow-Up Studies; D006801:Humans; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D013981:Tic Disorders / Q000150:complications* / Q000175:diagnosis; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride